Carbon nanotubes give cancer drugs a boost
Both graphene oxide and single-walled carbon nanotubes were found to enhance cancer-cell death in lung-cancer cells when combined with the Paclitaxel, indicating a synergistic effect that has been identified as reactive-oxygen species dependent.
Combination therapies, where more than one therapeutic agent is used to treat a cancer, were first developed to tackle heterogeneity in tumours – that is the presence of more than one type of cell. Typically this involves combinations of different drugs, but the use of carbon-based nanomaterials instead could lower the side effects experienced by patients, while still offering enhanced treatment effects.
Most read news
Original publication
Organizations
Other news from the department science
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.